Clinical Research
Total Trials
3
As Lead Sponsor
0
As Collaborator
Total Enrollment
79
NCT05712538
Safety, Tolerability, and Pharmacokinetics of ARCT-032 in Healthy Adult Subjects and Adults With Cystic Fibrosis.
Phase: Phase 1
Role: Collaborator
Start: Feb 15, 2023
Completion: Jul 29, 2024
NCT06008652
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DR-0201 in Healthy Adult Volunteers
Start: Nov 26, 2023
Completion: Jul 24, 2024
NCT06698861
A Phase I PK/PD Study of PEG-MetHuG-CSF (P2203) in Healthy Volunteers
Start: Aug 19, 2024
Completion: Feb 6, 2025
Loading map...